Physiokeys

Identification of candidate biomarkers for diagnosis, disease activity, and relapse prediction in IgG4-related disease.

Arthritis Research and Therapy2026

Predicting clinical response in psoriatic arthritis through integrative analysis of transcriptomics and proteomics.

Arthritis Research and Therapy2026

Human MAGI1 expression in endothelial cells protects from the development of localized and systemic scleroderma in mice.

Arthritis Research and Therapy2026

Predictors of glucocorticoid-free clinical remission in patients with newly diagnosed microscopic polyangiitis and granulomatosis with polyangiitis: a retrospective cohort study using a nationwide registry in Japan (J-CANVAS).

Arthritis Research and Therapy2026

Soluble factors released from fibroblast-like synoviocytes of JIA patients with future extended course can condition persistent JIA synovial fibroblasts for increased IL-6 production.

Arthritis Research and Therapy2026

Development and validation of a risk score for serious infection in patients with rheumatic diseases receiving prolonged high-dose glucocorticoids.

Arthritis Research and Therapy2026

An interpretable machine learning model integrating clinical and CT radiomic features for the detection of interstitial lung disease in idiopathic inflammatory myopathies.

Arthritis Research and Therapy2026

Sleep quality, duration, and multi-trajectories as predictors of rheumatoid arthritis: evidence from the english longitudinal study of ageing.

Arthritis Research and Therapy2026

Upadacitinib for refractory Behcet's syndrome: a multi-centre, single-arm trial.

Arthritis Research and Therapy2026

Synovial fluid potentiates local fibroblasts to drive monocyte activation in juvenile idiopathic arthritis.

Arthritis Research and Therapy2026

Risk factors of serious infections in patients with large-vessel vasculitis after the approval of tocilizumab in 2017: a retrospective nested case-control study using the Japanese health insurance database.

Arthritis Research and Therapy2026

Sleep improvement in patients with rheumatoid arthritis treated with upadacitinib in real-world practice: results from the SLEERA study.

Arthritis Research and Therapy2026

The challenges and opportunities for equitable global access to medications for paediatric rheumatology in low-to middle-income countries: a review on behalf of the Paediatric Global Task Force for Musculoskeletal Health.

Arthritis Research and Therapy2026

Novel advances in juvenile idiopathic arthritis associated uveitis.

Arthritis Research and Therapy2026

Correction: Physical activity in relation to health status, quality of life and compliance with world health organization recommendations in patients with axial spondyloarthritis.

Arthritis Research and Therapy2026

FASN-mediated metabolic reprogramming drives CD4 T cell hyperactivation in Sjögren's syndrome via fatty acid oxidation-dependent oxidative phosphorylation.

Arthritis Research and Therapy2026

Integrative multi-omics analysis reveals CXCL10-driven inflammation and TREM2 + macrophage-plasma cell survival niche as hallmarks of late-stage rheumatoid arthritis.

Arthritis Research and Therapy2026

The inhibition of miR-125b-5P prevented Treg differentiation through activating STAT3/HIF-1α pathway in PBMCs of ankylosing spondylitis.

Arthritis Research and Therapy2026

Decreased expression of circ-CCDC134 mediated by TNF-α in patients with rheumatoid arthritis affects T cell function via targeting protein phosphatase 2A.

Arthritis Research and Therapy2026

Establishing C-X-C motif chemokine receptor 4 as a novel imaging target in giant cell arteritis.

Arthritis Research and Therapy2026

Real-world validation of the SLERPI diagnostic model with concordance and discordance analysis across established SLE classification criteria.

Arthritis Research and Therapy2026

Subclinical atherosclerosis in rheumatoid arthritis is driven by MicroRNA polymorphisms and NETosis.

Arthritis Research and Therapy2026

Modulation of inflammatory pathways by omega-3 fatty acids in knee joint health for the management of post-traumatic osteoarthritis: a review.

Arthritis Research and Therapy2026

Effects of a personalized exercise program on physical function in older patients with rheumatoid arthritis at high risk of sarcopenia: results of a randomized controlled trial.

Arthritis Research and Therapy2026

Dynamic vascular changes on long-term ultrasound monitoring predict relapse in large-vessel giant cell arteritis.

Arthritis Research and Therapy2026

Sjögren's patient subgroups identified through whole genome DNA methylation profiling.

Arthritis Research and Therapy2026

TPI1 and TPM4 are strong candidate RNA biomarkers for systemic sclerosis.

Arthritis Research and Therapy2026

MSMP promotes an aberrant phenotype of fibroblast-like synoviocytes in rheumatoid arthritis by blocking autophagy via the RUNX1/GPR137B axis.

Arthritis Research and Therapy2026

IL-35 enhances IL-10⁺ breg-mediated immunoregulation and attenuates inflammation and fibrosis in systemic sclerosis.

Arthritis Research and Therapy2026

Reassessing the role of watchful waiting strategy for IgG4-related disease: a real-world study.

Arthritis Research and Therapy2026

Cyclovirobuxine D attenuates collagen-induced arthritis by inhibiting PI3K/AKT pathway and macrophage polarization.

Arthritis Research and Therapy2026

Association between physical activity and all-cause mortality in rheumatoid arthritis: evidence from NHANES and UK Biobank cohort studies.

Arthritis Research and Therapy2026

The rheumatoid arthritis citrullinome is enriched in antigenic complement proteins.

Arthritis Research and Therapy2026

Cytokine profiling of molecular endotypes of knee osteoarthritis: insights from the IMI-APPROACH cohort.

Arthritis Research and Therapy2026

Effects of pentosan polysulfate sodium on synovial fluid biomarkers in moderate to severe knee osteoarthritis: an exploratory, phase 2, randomized, double-blind, placebo-controlled trial.

Arthritis Research and Therapy2026

Frailty as an indicator of adverse health outcomes in rheumatoid arthritis: a multicenter cross-sectional study.

Arthritis Research and Therapy2026

Rheumatoid arthritis and gout: a rare combination or overlooked coexistence?

Arthritis Research and Therapy2026

Effects of anti-CD19 CAR-T cells in a murine model of IgG4-related disease.

Arthritis Research and Therapy2026

Global variation in the quality of care for rheumatoid arthritis and associated factors.

Arthritis Research and Therapy2026

Influence of major trauma and lower limb loss on radiographic progression and incidence of knee osteoarthritis and pain: a comparative and predictive analysis from the ADVANCE study.

Arthritis Research and Therapy2026

Mesenchymal stem cells attenuate systemic sclerosis related lung fibrosis by inhibiting T follicular helper cells in tertiary lymphoid structure.

Arthritis Research and Therapy2026

Dysregulation of YTHDF2 promotes the over expression of interferon beta in anti-MDA5 antibody-positive dermatomyositis.

Arthritis Research and Therapy2026

Knee muscle strength as a mediator of sex differences in incident knee osteoarthritis.

Arthritis Research and Therapy2026

Difficult to manage axial spondyloarthritis patients have high burden of pain-related comorbidities and adverse long-term outcome.

Arthritis Research and Therapy2026

Incidence and spectrum of primary respiratory disease throughout the course of rheumatoid arthritis: implications of structured repeated evaluation for detection and risk-factor analysis.

Arthritis Research and Therapy2026

Impact of symptom duration on the short- and long-term efficacy of bimekizumab in axial spondyloarthritis: results up to 2 years.

Arthritis Research and Therapy2026

Mental health needs of children and young people with arthritis.

Arthritis Research and Therapy2026

PARP-1 prevents osteoarthritis pathogenesis by inhibiting apoptosis in chondrocytes: an animal study.

Arthritis Research and Therapy2026

Mesenchymal stem cell exosomes alleviate osteoarthritis by inhibiting complement activation via a CD59-dependent pathway.

Arthritis Research and Therapy2026

A BAFF/APRIL dual inhibitor for the treatment of systemic lupus erythematosus: a long-term, observational, real-world study.

Arthritis Research and Therapy2026

Arthritis Research and Therapy

Latest articles